ciprofloxacin has been researched along with phenytoin in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (33.33) | 18.2507 |
| 2000's | 7 (23.33) | 29.6817 |
| 2010's | 13 (43.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Caron, G; Ermondi, G | 1 |
| Jolivette, LJ; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Sen, S; Sinha, N | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dillard, ML; Fink, RM; Parkerson, R | 1 |
| Arn, SK; D'Souza, MJ; Jacobs, NF; Job, ML; Strom, JG | 1 |
| Hull, RL | 1 |
| Pollak, PT; Slayter, KL | 2 |
| Brouwers, PJ; de Boer, LE; Guchelaar, HJ | 1 |
| Springuel, P | 1 |
| McLeod, R; Trinkle, R | 1 |
| Morán, D; Otero, MJ; Valverde, MP | 1 |
| Bhargava, VK; Garg, SK; Islam, AF | 1 |
| Bhadresa, S; Coon, DJ; Lawrence, MS; Magiera, D; Struharik, M; Ward, KW | 1 |
| Hanken, I; Sander, CA; Schimmer, M | 1 |
| Gribakina, OG; Kolyvanov, GB; Novitskaia, IaG; Seredenin, SB; Smirnov, VV; Zherdev, VP | 1 |
| Liew, EK; Malladi, SS; Ng, XT; Tan, RK | 1 |
| El-Kasapy, A; El-Sherbiny, IM; Khalil, IA; Mostafa, A; Osman, A; Salah, M; Shokry, MM | 1 |
1 review(s) available for ciprofloxacin and phenytoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
29 other study(ies) available for ciprofloxacin and phenytoin
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Ciprofloxacin-phenytoin interaction.
Topics: Aged; Ciprofloxacin; Drug Interactions; Humans; Male; Phenytoin; Seizures | 1992 |
Effect of ciprofloxacin on the pharmacokinetics of multiple-dose phenytoin serum concentrations.
Topics: Adult; Ciprofloxacin; Drug Interactions; Female; Humans; Male; Phenytoin | 1994 |
Possible phenytoin-ciprofloxacin interaction.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Drug Interactions; Epilepsy, Tonic-Clonic; Female; Humans; Phenytoin | 1993 |
Hazards of doubling phenytoin dose in the face of an unrecognized interaction with ciprofloxacin.
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Middle Aged; Phenytoin; Seizures | 1997 |
Ciprofloxacin-phenytoin interaction.
Topics: Aged; Anti-Infective Agents; Anticonvulsants; Ciprofloxacin; Drug Interactions; Humans; Male; Phenytoin; Pneumonia; Seizures | 1997 |
Comment: ciprofloxacin-phenytoin interaction.
Topics: Adult; Anti-Infective Agents; Anticonvulsants; Ciprofloxacin; Drug Administration Routes; Drug Interactions; Female; Humans; Infusions, Intravenous; Phenytoin | 1997 |
Risk of seizures from concomitant use of ciprofloxacin and phenytoin in patients with epilepsy.
Topics: Anti-Infective Agents; Anticonvulsants; Ciprofloxacin; Drug Interactions; Epilepsy; Humans; Phenytoin; Risk; Seizures | 1998 |
Comment: unexpectedly low phenytoin concentration in a patient receiving ciprofloxacin.
Topics: Aged; Anti-Infective Agents; Anticonvulsants; Ciprofloxacin; Drug Interactions; Female; Humans; Phenytoin; Seizures | 1998 |
Interaction between phenytoin and ciprofloxacin.
Topics: Anti-Infective Agents; Anticonvulsants; Ciprofloxacin; Drug Interactions; Female; Humans; Middle Aged; Phenytoin; Status Epilepticus; Urinary Tract Infections | 1999 |
Effect of ciprofloxacin on steady state pharmacokinetics of phenytoin in rabbits.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Male; Phenytoin; Rabbits | 1999 |
Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions.
Topics: Animals; Aza Compounds; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Evaluation, Preclinical; Erythromycin; Fluoroquinolones; Lidocaine; Mass Spectrometry; Models, Animal; Moxifloxacin; Pharmacokinetics; Phenytoin; Prednisolone; Propranolol; Quinolines; Species Specificity | 2009 |
Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticonvulsants; Bacterial Infections; Ciprofloxacin; Drug Combinations; Female; Folic Acid; Gout Suppressants; Humans; Hydroxocobalamin; Lidocaine; Male; Middle Aged; Phenytoin; Prednisone; Pyridoxine; Stevens-Johnson Syndrome; Superinfection; Survival Rate; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
[In vivo evaluation of the metabolic ratio of CYP2C9 and CYP1A2 drug markers after administration of afobazole in comparison to standard inducers and inhibitors of cytochromes].
Topics: Animals; Anti-Anxiety Agents; Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Benzimidazoles; Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Cytochromes; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Male; Morpholines; Phenytoin; Rats; Rifampin | 2013 |
Ciprofloxacin eye drops-induced subtherapeutic serum phenytoin levels resulting in breakthrough seizures.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Interactions; Epilepsy, Temporal Lobe; Female; Hospitalization; Humans; Ophthalmic Solutions; Phenytoin; Psychotic Disorders; Seizures | 2014 |
Multifunctional prosthetic polyester-based hybrid mesh for repairing of abdominal wall hernias and defects.
Topics: Abdominal Wall; Alginates; Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Dogs; Drug Delivery Systems; Female; Hernia, Abdominal; Male; Micelles; Phenytoin; Polyesters; Prostheses and Implants; Surgical Mesh; Wound Healing | 2019 |